ITM AG

ITM AG

A privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2007200820092010201120122013
Profit(<1m)(<1m)(<1m)(<1m)(<1m)<1m(<1m)
  • Edit
DateInvestorsAmountRound
-

N/A

-

€90.0m

Convertible
*

€25.0m

Growth Equity VC
*

€33.0m

Growth Equity VC
Total Funding€148m

Recent News about ITM AG

Edit